{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:06:29Z","timestamp":1779883589823,"version":"3.53.1"},"reference-count":98,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Basilea Pharmaceutica International Ltd, Allschwil"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/14787210.2026.2672541","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:38:01Z","timestamp":1778495881000},"page":"489-499","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Invasive mold infections in the pediatric setting: current status and new developments"],"prefix":"10.1080","volume":"24","author":[{"given":"Adilia","family":"Warris","sequence":"first","affiliation":[{"name":"University of Exeter, Exeter","place":["UK"]},{"name":"Great Ormond Street Hospital for Children NHS Foundation Trust","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rojo","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital","place":["M\u00fcnster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Arrieta","sequence":"additional","affiliation":[{"name":"University of California","place":["Irvine, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu074"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30723-3"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00926-2"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002317"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071317"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012247"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08314-9"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.05.016"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27915"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw557"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08072.x"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27564"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix046"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107058"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010145"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000159"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piae079"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.03.019"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000875"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-091942"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027904"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1056489"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2016.08.011"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0160-2"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.15702"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa119"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix041"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31825f95b9"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.01.047"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00158"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00094-21"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae337"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.845540"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12660"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29275"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy213"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-4726-9_3"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1154"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000101"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir786"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2117"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02224"},{"key":"e_1_3_5_46_1","first-page":"174","article-title":"Clinical utility and development of biomarkers in invasive aspergillosis","volume":"122","author":"Patterson TF","year":"2011","unstructured":"Patterson TF. Clinical utility and development of biomarkers in invasive aspergillosis. Trans Am Clin Climatol Assoc. 2011;122:174\u2013183.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu677"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2013.804033"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw592"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03276-20"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75132-3"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof8121262"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof9100967"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15151909"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-020-00611-7"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1639"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae252"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf021"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01236-24"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPEMVYT88AVFKG"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa498"},{"issue":"5","key":"e_1_3_5_62_1","first-page":"410","article-title":"Clinical practice update of antifungal prophylaxis in immunocompromised children","volume":"32","author":"Ramos JT","year":"2019","unstructured":"Ramos JT, Romero CA, Belda S, et al. Clinical practice update of antifungal prophylaxis in immunocompromised children. Rev Esp Quimioter. 2019;32(5):410\u2013425.","journal-title":"Rev Esp Quimioter"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.05.019"},{"key":"e_1_3_5_64_1","unstructured":"Merck Sharpe & Dohme. Noxafil summary of product characteristics. [cited 2025 May 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/noxafil-epar-product-information_en.pdf"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1086\/597395"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky244"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac352"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111961"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220407094430"},{"key":"e_1_3_5_70_1","unstructured":"Pfizer. VFEND summary of product characteristics. [cited 2025 May 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vfend-epar-product-information_en.pdf"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020191"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12834"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1161"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1292163"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106711"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00626-12"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-016-0255-4"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.05.037"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6010028"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky280"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01992-20"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof7030163"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.05.013"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf005"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040239"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01735-19"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460913.2024.2362128"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040324"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10030106"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00071-2"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27281"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002671"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae371"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00290-21"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00484-24"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1086\/588660"},{"key":"e_1_3_5_98_1","volume-title":"CRESEMBA\u00ae (isavuconazonium sulfate) capsules, for oral use [package insert]","year":"2023","unstructured":"CRESEMBA\u00ae (isavuconazonium sulfate) capsules, for oral use [package insert]. Northbrook (IL): Astellas Pharma US, Inc.; 2023."},{"key":"e_1_3_5_99_1","unstructured":"CRESEMBA. CRESEMBA summary of product characteristics. [cited 2025 May 15]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cresemba-epar-product-information_en.pdf"},{"key":"e_1_3_5_100_1","volume-title":"6th European Conference on Infections in Leukemia","author":"Lewis R","year":"2015","unstructured":"Lewis R, Br\u00fcggemann R, Padoin C, et al. Triazole antifungal therapeutic drug monitoring. In: 6th European Conference on Infections in Leukemia; France. Sophia Antipolis; 2015 Sep 11\u201312 [cited 2025 May 15]. Available from: https:\/\/www.ecil-leukaemia.com\/images\/resources\/2015\/5_ECIL6-Triazole-TDM-07-12-2015-Lewis-R-et-al.pdf"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2672541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:10:46Z","timestamp":1779880246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2026.2672541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/14787210.2026.2672541"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2026.2672541","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}